Global B2B Pharmaceutical Sourcing Β· Dossier Licensing Β· Named-Patient Access
πŸ’¬ WhatsApp Β· Sign in Β· Register

Heart Disorder β€” Manufacturers, Suppliers & Exporters

Can't find the Heart Disorder product you need?
Send us an RFP β€” our team sources it from verified manufacturers and reverts with quotes.
Send RFP β†’

Browse Heart Disorder products

Felodipine

Strength: 2.5 mg, 5 mg, 10 mg

Form: Tablets

Reference Brands: Plendil (USA/ EU), Felodur (EU), Renedil (EU/UK)

View Details Get Enquiry

Fenofibrate Caplets and Capsules

Strength: 67 mg, 135 mg, 160 mg, and 145 mg

Form: Caplets and Capsules

Reference Brands: Tricor(US), Fenogal, Lipanor(EU)

View Details Get Enquiry

Flecainide Tablet

Strength: 50 mg, 100 mg tablets

Form: Tablet

Reference Brands: Tambocor(EU & US)

View Details Get Enquiry

FLUVASTATIN SODIUM

Strength: 20 mg, 40 mg, 80 mg

Form: Tablets / Capsules

Reference Brands: Lescol (USA), Canef (EU), Vastin (EU)

View Details Get Enquiry

Fosinopril sodium

Strength: 10 mg, 20 mg, 40 mg

Form: Tablets

Reference Brands: Monopril (USA/EU)

View Details Get Enquiry

Frusemide Injection

Strength: 50 mg/ml

Form: Injection

Reference Brands: Lasix (India/EU), Frusid (LATAM)

View Details Get Enquiry

Furosemide tablets

Strength: 20 mg, 40 mg, and 80 mg tablets

Form: Tablet

Reference Brands: Lasix(US & EU)

View Details Get Enquiry

Gemfibrozil tablet/ Capsule

Strength: 600 mg

Form: Tablet/Capsules

Reference Brands: Lopid(US & EU)

View Details Get Enquiry

Ibutilide Fumarate

Strength: 0.1 mg /ml

Form: Injection

Reference Brands: Corvert (USA)

View Details Get Enquiry

Icosapent Ethyl

Strength: 1 g

Form: Capsules

Reference Brands: Vascepa (USA), Vazkepa (EU/UK)

View Details Get Enquiry

Inamrinone Lactate

Strength: 10 mg/mL

Form: Injection

Reference Brands: Generic formulations marketed under different names

View Details Get Enquiry

Inclisiran

Strength: 300 mg

Form: injection (prefilled syringe)

Reference Brands: Leqvio (USA/EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.